Pioglitazone
Thiazolidinedione (TZD) reference compound. Selective PPARgamma agonist. Selectively activates PPARgamma-1. Anti-diabetic , decreasing insulin resistance in adipose tissue. Is about one tenth as potent as rosiglitazone. Lipid metabolism modulator. Estrogen synthesis inhibitor. NF-kappaB inhibitor. Neuroprotective.
| Catalog Number | AG-CR1-0067-M005 |
| Alternative Name(s) | 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl-2,4-thiazolidinedione |
| Research Area | Biochemicals, Metabolism |
| Molecular Formula | C19H20N2O3S |
| CAS# | 111025-46-8 |
| Purity | >98% |
| Inchi | 1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23) |
| Inchi Key | HYAFETHFCAUJAY-UHFFFAOYSA-N |
| SMILES | CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1 |
| Size | 5 mg |
| Supplier Page | http://www.adipogen.com/ag-cr1-0067/pioglitazone.html |